Green tea extract (GTE) has shown potential to prevent Parkinson's, Alzheimer's, diabetes, and cancer (Cheng et al., 2019;Yu et al., 2017).The high incidence of these diseases is attracting attention to the GTE's benefits, increasing its global demand. The estimated account for the tea extracts market was USD 2.5 billion in 2019 and is projected to reach a value of USD 3.8 billion by 2025 (Markets & Markets, 2020). GTE contains epigallocatechin (EGC), epigallocatechin gallate (EGCG), and epicatechin gallate (ECG) as bioactive constituents; however, their activity could be compromised during drying, withering, grinding, extraction (solvent, time, temperature, pH), and storage conditions (Munin & Edwards-Lévy, 2011).Catechin degradation mainly consists of structural changes, epimerization, oxidation, and polymerization, generating different byproducts with lower antioxidant capacity (Ananingsih et al., 2013;